Meeting on the Mesa 2020 | The potential of RegenMed in the oncology space

Helen Tayton-Martin, PhD, Adaptimmune, Oxford, UK, speaks on the reformative nature of regenerative medicine. Dr Taytor-Martin highlights cell and gene therapies in the oncology setting, and how these technologies may represent a potential paradigm shift in the future. This interview took place during the 2020 Meeting on the Mesa congress.